News

Dr. Celine Gounder joins CBS Mornings to break down the FDA-approved drug Lenacapavir, which is being called the closest step ...
Despite significant advancements in HIV treatment and prevention, researchers continue to seek a cure. This article explores ...
The drug, in June, received FDA approval as the first twice-yearly pre-exposure prophylaxis (PrEP) option to reduce the risk ...
Scientific research has gifted us with a range of evidence-based options to protect ourselves from getting infected with HIV.
Analysts believe that Gilead's new PrEP drug Yeztugo could reach peak sales of $4.5 billion. Not if GSK has anything to say about it.
The Makerere University–Johns Hopkins University Research Collaboration has announced ongoing studies aimed at extending the ...
This discovery could make treatment for an eye disease affecting millions with diabetes more accessible and affordable.
A federal judge says that recent layoffs at the U.S. Department of Health and Human Services were likely unlawful and must be ...
A federal judge has ruled that recent mass layoffs at the US Department of Health and Human Services were likely unlawful and ...
Japan’s lack of generic PrEP options has made therapies inaccessible to most patients. Access to newer HIV therapies remains ...